Interestingly, the IGF2BP1, IGF2BP2, and HNRNPC genes displayed strong prognostic performance in adenocarcinoma, as validated in two independent cohorts of patients [50]. The gene discussed is IGF2BP2; the disease is adenocarcinoma.